Iron intake, red cell indicators of iron status, and DNA damage in young subjects

Nutrition

Volumn 27, Issue 3, 2011, Pages 293-297

  Prá, Daniel ^a,b,c   Bortoluzzi, Angelica ^a   Müller, Luiza Louzada ^a   Hermes, Liziane ^a   Horta, Jorge André ^a   Maluf, Sharbel Weidner ^d   Henriques, João Antonio Pêgas ^e   Fenech, Michael ^b   Franke, Silvia Isabel Rech ^a  

^a UNIVERSITY OF SANTA CRUZ DO SUL   (Brazil)

^b CSIRO   (Australia)

^c CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Anemia; DNA damage; Iron; Micronucleus; Micronutrients

Indexed keywords

CELL MARKER; HEMOGLOBIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CHILD; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CLINICAL INDICATOR; COMET ASSAY; CONTROLLED STUDY; CYTOKINESIS; DISEASE SEVERITY; DNA DAMAGE; FEMALE; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; IRON INTAKE; MALE; MEAN CORPUSCULAR VOLUME; MICRONUCLEUS TEST; NUTRITIONAL STATUS; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL STATUS;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; CHILD; CHROMOSOME BREAKAGE; DIET RECORDS; DNA DAMAGE; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HEMOGLOBINS; HUMANS; IRON, DIETARY; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NUTRITIONAL REQUIREMENTS; QUESTIONNAIRES;

EID: 79951555043     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.02.001     Document Type: Article

References (59)

1. Ames B.N., Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk?. Nat Rev Cancer 2002, 2:694-704.
2. Beard J.L. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001, 131:568S-580S.
3. Walter P.B., Knutson M.D., Paler-Martinez A., Lee S., Xu Y., Viteri F.E., et al. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. PNAS 2002, 99:2264-2269.
4. Atamna H., Killilea D.W., Killilea A.N., Ames B.N. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. PNAS 2002, 99:14807-14812.
5. Prá D., Franke S.I.R., Henriques J.A.P., Fenech M. A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer 2009, 61:415-426.
6. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 2004, 77:681-689.
7. Arredondo M., Nunez M.T. Iron and copper metabolism. Mol Aspects Med 2005, 26:313-327.
8. Aslan M., Horoz M., Kocyigit A., Ozgonul S., Celik H., Celik M., et al. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat Res 2006, 601:144-149.
9. Diaz-Castro J., Alferez M.J., Lopez-Aliaga I., Nestares T., Granados S., Barrionuevo M., et al. Influence of nutritional iron deficiency anemia on DNA stability and lipid peroxidation in rats. Nutrition 2008, 24:1167-1173.
10. Friedrisch J.R., Prá D., Maluf S.W., Bittar C.M., Mergener M., Pollo T., et al. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res 2007, 649:213-220.
11. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutat Res 1985, 147:29-36.
12. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993, 285:35-44.
13. Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat Res 1997, 392:11-18.
14. Fenech M., Crott J.W. Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat Res 2002, 504:131-136.
15. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. WHO/NHD/01.3 2001, World Health Organization, United Nations University, United Nations Children's Fund, World Health Organization, Geneva.
16. Massey A.C. Microcytic anemia. Differential diagnosis and management of iron deficiency anemia. Med Clin North Am 1992, 76:549-566.
17. Wright R.O., Shannon M.W., Wright R.J., Hu H. Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health 1999, 89:1049-1053.
18. Must A., Dallal G.E., Dietz W.H. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991, 53:839-846.
19. Fisberg R.M., Slater B., Marchione D.M.L. Martini LA Inquéritos alimentares: métodos e bases científica. Barueri: Manole Ltda 2005.
20. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, molybdenum, nickel, silicon, vanadium and zinc 2001, Institute of Medicine, Food and Nutrition Board, National Academy Press, Washington, Dc.
21. Ames B.N. Micronutrients prevent cancer and delay aging. Toxicol Lett 1998, 102-3:5-18.
22. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 2001, 480-1:51-54.
23. Ames B.N. A role for supplements in optimizing health: the metabolic tune-up. Arch Biochem Biophys 2004, 423:227-234.
24. Kalinowski D.S., Richardson D.R. Future of toxicology-iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy. Chem Res Toxicol 2007, 20:715-720.
25. Thelander L. Ribonucleotide reductase and mitochondrial DNA synthesis. Nat Genet 2007, 39:703-704.
26. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007, 39:776-780.
27. Brzoska K., Meczynska S., Kruszewski M. Iron-sulfur cluster proteins: electron transfer and beyond. Acta Biochim Pol 2006, 53:685-691.
28. Mishina Y., He C. Oxidative dealkylation DNA repair mediated by the mononuclear non-heme iron AlkB proteins. J Inorg Biochem 2006, 100:670-678.
29. Goth L., Vitai M. Hypocatalasemia in hospital patients. Clin Chem 1996, 42:341-342.
30. Macdougall L.G. Red cell metabolism in iron deficiency anemia: III. The relationship between glutathione peroxidase, catalase, serum vitamin E, and susceptibility of iron-deficient red cells to oxidative hemolysis. J Pediatr 1972, 80:775-782.
31. Tanswell A.K., Freeman B.A. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. II. The influence of maternal iron supplements upon fetal lung catalase activity. Pediatr Res 1984, 18:871-874.
32. Bristow-Craig H.E., Strain J.J., Welch R.W. Iron status, blood lipids and endogenous antioxidants in response to dietary iron levels in male and female rats. Int J Vitam Nutr Res 1994, 64:324-329.
33. Kurtoglu E., Ugur A., Baltaci A.K., Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res 2003, 96:117-123.
34. Dhur A., Galan P., Hercberg S. Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat. J Nutr 1989, 119:40-47.
35. Ames B.N., Atamna H., Killilea D.W. Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging. Mol Aspects Med 2005, 26:363-378.
36. Goldblatt M.I., Choi S.-H., Swartz-Basile D.A., Nakeeb A., Sarna S.K., Pitt H.A. Iron deficiency suppresses ileal nitric oxide synthase activity. J Gastrointest Surg 2001, 5:393-400.
37. Harhaji L., Vuckovic O., Miljkovic D., Stosic-Grujicic S., Trajkovic V. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production. Clin Exp Immunol 2004, 137:109-116.
38. Fenech M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 2005, 20:255-269.
39. Singh M., Sanderson P., Hurrell R.F., Fairweather-Tait S.J., Geissler C., Prentice A., et al. Iron bioavailability: UK Food Standards Agency workshop report. Br J Nutr 2006, 96:985-990.
40. Teucher B., Olivares M., Cori H. Enhancers of iron absorption: ascorbic acid and other organic acids. Int J Vitam Nutr Res 2004, 74:403-419.
41. Gibson R.S. The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based requirement estimates. Food Nutr Bull 2007, 28:S77-100.
42. Powers H.J. Riboflavin-iron interactions with particular emphasis on the gastrointestinal-tract. Proc Nutr Soc 1995, 54:509-517.
43. Suprapto B. Widardo, Suhanantyo. Effect of low-dosage vitamin A and riboflavin on iron-folate supplementation in anaemic pregnant women. Asia Pac J Clin Nutr 2002, 11:263-267.
44. Zimmermann M.B. The influence of iron status on iodine utilization and thyroid function. Annu Rev Nutr 2006, 26:367-389.
45. Atamna H. Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 2004, 3:303-318.
46. Killip S., Bennett J.M., Chambers M.D. Iron deficiency anemia. Am Fam Phys 2007, 75:671-678.
47. Davenport J. Macrocytic anemia. Am Fam Phys 1996, 53:155-162.
48. Subramanian D.N., Kitson S., Bhaniani A. Microcytosis and possible early iron deficiency in paediatric inpatients: a retrospective audit. BMC Pediatr 2009, 9:36.
49. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
50. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009, 1790:682-693.
51. Maluf S., Prá D., Friedrisch J.R., Bittar C., da Silva M.A.L., Henriques J.A., et al. Length of treatment and dose as determinants of mutagenicity in sickle cell disease patients treated with hydroxyurea. Environ Toxicol Pharmacol 2009, 27:26-29.
52. Friedrisch J.R., Pra D., Maluf S.W., Bittar C.M., Mergener M., Pollo T., et al. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res 2008, 649:213-220.
53. Ortiz R., Cortes E., Gonzalez C., Perez L., Betancourt M. Micronucleus frequency in spleen lymphocytes from severely malnourished rats during lactation. Environ Mol Mutagen 1995, 26:55-59.
54. Cortes E., Gonzalez C., Betancourt M., Ortiz R. Assessment of DNA damage in spleen, bone marrow, and peripheral blood from malnourished rats by single cell gel electrophoresis assay. Teratog Carcinog Mutagen 2001, 21:231-247.
55. González C., Nájera O., Cortés E., Toledo G., López L., Betancourt M., et al. Hydrogen peroxide-induced DNA damage and DNA repair in lymphocytes from malnourished children. Environ Mol Mutagen 2002, 39:33-42.
56. Padula G., Salceda S.A., Seoane A.I. Protein-energy malnutrition contributes to increased structural chromosomal alteration frequencies in Argentinean children. Nutr Res 2009, 29:35-40.
57. Jackson A.L., Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001, 477:7-21.
58. Betancourt M., Ortiz R., Gonzalez C., Perez P., Cortes L., Rodriguez L., et al. Assessment of DNA damage in leukocytes from infected and malnourished children by single cell gel electrophoresis/comet assay. Mutat Res 1995, 331:65-77.
59. Lund E.K., Wharf S.G., Fairweather-Tait S.J., Johnson I.T. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 1999, 69:250-255.